This company has been acquired
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Cardiovascular Systems Résultats passés
Passé contrôle des critères 0/6
Informations clés
-54.5%
Taux de croissance des bénéfices
-52.3%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 8.9% |
| Taux de croissance des recettes | 2.1% |
| Rendement des fonds propres | -15.8% |
| Marge nette | -15.8% |
| Dernière mise à jour des bénéfices | 31 Dec 2022 |
Mises à jour récentes des performances passées
Recent updates
We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate
Feb 03
We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely
Oct 12Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates
Aug 03Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns
Nov 05Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?
Oct 09At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?
Sep 18Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?
Jun 24Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Jun 03We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow
Apr 29Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Mar 17Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain
Feb 10Cardiovascular Systems misses on revenue
Feb 03Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares
Dec 11
Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation
Nov 06Ventilation des recettes et des dépenses
Comment Cardiovascular Systems gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Dec 22 | 240 | -38 | 174 | 36 |
| 30 Sep 22 | 238 | -39 | 173 | 36 |
| 30 Jun 22 | 236 | -37 | 171 | 37 |
| 31 Mar 22 | 245 | -33 | 170 | 37 |
| 31 Dec 21 | 252 | -29 | 169 | 41 |
| 30 Sep 21 | 257 | -20 | 169 | 42 |
| 30 Jun 21 | 259 | -13 | 167 | 41 |
| 31 Mar 21 | 231 | -23 | 157 | 39 |
| 31 Dec 20 | 228 | -20 | 157 | 36 |
| 30 Sep 20 | 233 | -24 | 163 | 37 |
| 30 Jun 20 | 237 | -27 | 170 | 39 |
| 31 Mar 20 | 262 | -11 | 179 | 41 |
| 31 Dec 19 | 264 | -7 | 179 | 40 |
| 30 Sep 19 | 256 | -3 | 173 | 37 |
| 30 Jun 19 | 248 | 0 | 168 | 32 |
| 31 Mar 19 | 239 | 2 | 162 | 30 |
| 31 Dec 18 | 231 | 2 | 158 | 29 |
| 30 Sep 18 | 224 | 1 | 154 | 28 |
| 30 Jun 18 | 217 | 2 | 149 | 27 |
| 31 Mar 18 | 211 | -1 | 145 | 26 |
| 31 Dec 17 | 207 | -3 | 145 | 24 |
| 30 Sep 17 | 205 | -2 | 142 | 24 |
| 30 Jun 17 | 205 | -2 | 144 | 23 |
| 31 Mar 17 | 199 | -7 | 146 | 23 |
| 31 Dec 16 | 191 | -28 | 149 | 23 |
| 30 Sep 16 | 183 | -45 | 157 | 24 |
| 30 Jun 16 | 177 | -56 | 161 | 26 |
Des revenus de qualité: CSII is currently unprofitable.
Augmentation de la marge bénéficiaire: CSII is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: CSII is unprofitable, and losses have increased over the past 5 years at a rate of 54.5% per year.
Accélération de la croissance: Unable to compare CSII's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: CSII is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-5.5%).
Rendement des fonds propres
ROE élevé: CSII has a negative Return on Equity (-15.82%), as it is currently unprofitable.